IDiyas

For the Inventor, By the Inventor

Los Altos Hills, CA, United States of America

Jacob Berger

USPTO Granted Patents = 23 


 

Average Co-Inventor Count = 3.9

ph-index = 8

Forward Citations = 273(Granted Patents)


Location History:

  • Los Altos, CA (US) (2005)
  • Los Altos Hills, CA (US) (1986 - 2013)

Company Filing History:

goldMedal15 out of 932 
 
Syntex (u.s.a.) Inc.
 patents
silverMedal8 out of 322 
 
Roche Palo Alto LLC
 patents

Years Active: 1986-2013

Loading Chart...
Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents
1. 8377931 - Benzoxazine derivatives and uses thereof (2013-02-19),
2. 8372865 - [object Object] (2013-02-12),
3. 8288552 - [object Object] (2012-10-16),
4. 8163929 - [object Object] (2012-04-24),
5. 7754759 - [object Object] (2010-07-13),
6. 7368567 - Arylsulfonyl benzodioxanes, benzoxazines and benzothiazines as 5-HT6 antagonists (2008-05-06),
7. 7202241 - Benzoxazine derivatives and uses thereof (2007-04-10),
8. 6867204 - Benzoxazine derivatives and uses thereof (2005-03-15),
9. 6825202 - Arylsulfonyl derivatives with 5-HT6 receptor affinity (2004-11-30),
10. 5958934 - Aryl pyrimidine derivatives and uses thereof (1999-09-28),
11. 5952331 - Aryl pyrimidine derivatives (1999-09-14),
12. 5863924 - Aryl pyrimidine derivatives (1999-01-26),
13. 5739336 - 1,3,8-triaza- and 3,8-diaza-1-oxaspiro �4,5! decane derivatives (1998-04-14),
14. 5688830 - Treatment of neuropathic pain (1997-11-18),
15. 5492914 - 2-(1-azabicyclo[2.2.2]oct-3 s-yl)-6-hydroxy-2,4,5,6-tetrahydro-1H-benz[DE]i (1996-02-20),

Title: The Innovative Journey of Jacob Berger in Benzoxazine Derivatives

Introduction

Jacob Berger is an accomplished inventor based in Los Altos Hills, California, with an impressive portfolio consisting of 23 patents. His work primarily focuses on the development and application of benzoxazine derivatives, showcasing his commitment to advancing pharmaceutical science.

Latest Patents

Among his latest inventions, Berger has developed compounds described in his patent related to benzoxazine derivatives. The present invention provides a compound of a specific formula, including a pharmaceutically acceptable salt or a prodrug thereof. This innovative compound offers various compositions and methods for use, especially in treating diseases associated with the P2X7 purinergic receptor. Moreover, the invention includes detailed methodologies for both the preparation and application of these compounds, emphasizing their potential impact on healthcare.

Career Highlights

Throughout his career, Jacob Berger has worked with prominent companies in the pharmaceutical industry. He has contributed significantly to Syntex Inc. and Roche Palo Alto LLC, where he has honed his skills and expertise in developing innovative pharmaceutical solutions. His experience at these leading institutions has been pivotal to his success as an inventor.

Collaborations

Jacob has collaborated with notable professionals in the field, including Robin D. Clark and Shu-Hai Zhao. These partnerships have not only enhanced his research capabilities but also fostered a collaborative environment conducive to innovation and discovery within the realm of pharmaceuticals.

Conclusion

With a robust collection of 23 patents and a strong background in pharmaceutical research, Jacob Berger stands as a prominent figure in the field of innovation. His latest work on benzoxazine derivatives illustrates his dedication to addressing pressing health challenges. As he continues to explore new frontiers in pharmaceutical compounds, Berger’s contributions will undoubtedly play a significant role in the future of medical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…